Literature DB >> 25205117

Role for early-differentiated natural killer cells in infectious mononucleosis.

Tarik Azzi1, Anna Lünemann1, Anita Murer2, Seigo Ueda3, Vivien Béziat4, Karl-Johan Malmberg5, Georg Staubli6, Claudine Gysin7, Christoph Berger1, Christian Münz2, Obinna Chijioke8, David Nadal1.   

Abstract

A growing body of evidence suggests that the human natural killer (NK)-cell compartment is phenotypically and functionally heterogeneous and is composed of several differentiation stages. Moreover, NK-cell subsets have been shown to exhibit adaptive immune features during herpes virus infection in experimental mice and to expand preferentially during viral infections in humans. However, both phenotype and role of NK cells during acute symptomatic Epstein-Barr virus (EBV) infection, termed infectious mononucleosis (IM), remain unclear. Here, we longitudinally assessed the kinetics, the differentiation, and the proliferation of subsets of NK cells in pediatric IM patients. Our results indicate that acute IM is characterized by the preferential proliferation of early-differentiated CD56(dim) NKG2A(+) immunoglobulin-like receptor(-) NK cells. Moreover, this NK-cell subset exhibits features of terminal differentiation and persists at higher frequency during at least the first 6 months after acute IM. Finally, we demonstrate that this NK-cell subset preferentially degranulates and proliferates on exposure to EBV-infected B cells expressing lytic antigens. Thus, early-differentiated NK cells might play a key role in the immune control of primary infection with this persistent tumor-associated virus.
© 2014 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25205117      PMCID: PMC4199955          DOI: 10.1182/blood-2014-01-553024

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  57 in total

Review 1.  Infectious mononucleosis.

Authors:  Katherine Luzuriaga; John L Sullivan
Journal:  N Engl J Med       Date:  2010-05-27       Impact factor: 91.245

Review 2.  Evolutionary struggles between NK cells and viruses.

Authors:  Lewis L Lanier
Journal:  Nat Rev Immunol       Date:  2008-03-14       Impact factor: 53.106

3.  AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome.

Authors:  Markus Kalla; Anne Schmeinck; Martin Bergbauer; Dagmar Pich; Wolfgang Hammerschmidt
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

4.  HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection.

Authors:  Galit Alter; Suzannah Rihn; Katharine Walter; Anne Nolting; Maureen Martin; Eric S Rosenberg; Jeffrey S Miller; Mary Carrington; Marcus Altfeld
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

5.  Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection.

Authors:  Enrico Brunetta; Manuela Fogli; Stefania Varchetta; Luisa Bozzo; Kelly L Hudspeth; Emanuela Marcenaro; Alessandro Moretta; Domenico Mavilio
Journal:  AIDS       Date:  2010-01-02       Impact factor: 4.177

6.  Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation.

Authors:  Luca Vago; Barbara Forno; Maria Pia Sormani; Roberto Crocchiolo; Elisabetta Zino; Simona Di Terlizzi; Maria Teresa Lupo Stanghellini; Benedetta Mazzi; Serena K Perna; Attilio Bondanza; Derek Middleton; Alessio Palini; Massimo Bernardi; Rosa Bacchetta; Jacopo Peccatori; Silvano Rossini; Maria Grazia Roncarolo; Claudio Bordignon; Chiara Bonini; Fabio Ciceri; Katharina Fleischhauer
Journal:  Blood       Date:  2008-07-21       Impact factor: 22.113

7.  Fully functional NK cells after unrelated cord blood transplantation.

Authors:  V Beziat; S Nguyen; S Lapusan; B Hervier; N Dhedin; D Bories; M Uzunov; A Boudifa; H Trebeden-Negre; F Norol; Z Marjanovic; J-P Marie; J-P Vernant; P Debre; B Rio; V Vieillard
Journal:  Leukemia       Date:  2009-01-08       Impact factor: 11.528

8.  Analysis of the KIR repertoire in human NK cells by flow cytometry.

Authors:  Niklas K Björkström; Cyril Fauriat; Yenan T Bryceson; Johan K Sandberg; Hans-Gustaf Ljunggren; Karl-Johan Malmberg
Journal:  Methods Mol Biol       Date:  2010

9.  Adaptive immune features of natural killer cells.

Authors:  Joseph C Sun; Joshua N Beilke; Lewis L Lanier
Journal:  Nature       Date:  2009-01-11       Impact factor: 49.962

10.  Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes.

Authors:  Galit Alter; Maureen P Martin; Nickolas Teigen; William H Carr; Todd J Suscovich; Arne Schneidewind; Hendrik Streeck; Michael Waring; Angela Meier; Christian Brander; Jeffrey D Lifson; Todd M Allen; Mary Carrington; Marcus Altfeld
Journal:  J Exp Med       Date:  2007-11-19       Impact factor: 14.307

View more
  73 in total

Review 1.  Infectious Mononucleosis.

Authors:  Samantha K Dunmire; Kristin A Hogquist; Henry H Balfour
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

2.  The interplay between local immune response and Epstein-Barr virus-infected tonsillar cells could lead to viral infection control.

Authors:  Aldana G Vistarop; Melina Cohen; Fuad Huaman; Lucia Irazu; Marcelo Rodriguez; Elena De Matteo; María Victoria Preciado; Paola A Chabay
Journal:  Med Microbiol Immunol       Date:  2018-07-25       Impact factor: 3.402

3.  Characterization of a human anti-tumoral NK cell population expanded after BCG treatment of leukocytes.

Authors:  Eva M García-Cuesta; Gloria Esteso; Omodele Ashiru; Sheila López-Cobo; Mario Álvarez-Maestro; Ana Linares; Mei M Ho; Luis Martínez-Piñeiro; Hugh T Reyburn; Mar Valés-Gómez
Journal:  Oncoimmunology       Date:  2017-02-21       Impact factor: 8.110

4.  Patients With Natural Killer (NK) Cell Chronic Active Epstein-Barr Virus Have Immature NK Cells and Hyperactivation of PI3K/Akt/mTOR and STAT1 Pathways.

Authors:  Matthew K Howe; Kennichi Dowdell; Hye Sun Kuehn; Qingxue Li; Geoffrey T Hart; Doreen Garabedian; Kelly Liepshutz; Amy P Hsu; Hua Su; Julie E Niemela; Jennifer L Stoddard; Gulbu Uzel; Evan Shereck; Laura Schulz; Tatyana Feldman; Sergio D Rosenzweig; Eric O Long; Lesia Dropulic; Jeffrey I Cohen
Journal:  J Infect Dis       Date:  2020-09-01       Impact factor: 5.226

Review 5.  Diversification of human NK cells: Lessons from deep profiling.

Authors:  Aaron J Wilk; Catherine A Blish
Journal:  J Leukoc Biol       Date:  2018-01-19       Impact factor: 4.962

Review 6.  The Immune Response to Epstein Barr Virus and Implications for Posttransplant Lymphoproliferative Disorder.

Authors:  Olivia M Martinez; Sheri M Krams
Journal:  Transplantation       Date:  2017-09       Impact factor: 4.939

7.  Severe Symptomatic Primary Human Cytomegalovirus Infection despite Effective Innate and Adaptive Immune Responses.

Authors:  Raphaëlle Riou; Céline Bressollette-Bodin; David Boutoille; Katia Gagne; Audrey Rodallec; Maeva Lefebvre; François Raffi; David Senitzer; Berthe-Marie Imbert-Marcille; Christelle Retière
Journal:  J Virol       Date:  2017-02-14       Impact factor: 5.103

8.  Cognate HLA absence in trans diminishes human NK cell education.

Authors:  Vanessa Landtwing; Ana Raykova; Gaetana Pezzino; Vivien Béziat; Emanuela Marcenaro; Claudine Graf; Alessandro Moretta; Riccarda Capaul; Andrea Zbinden; Guido Ferlazzo; Karl-Johan Malmberg; Obinna Chijioke; Christian Münz
Journal:  J Clin Invest       Date:  2016-08-29       Impact factor: 14.808

9.  Poorly cytotoxic terminally differentiated CD56negCD16pos NK cells accumulate in Kenyan children with Burkitt lymphomas.

Authors:  Catherine S Forconi; Cormac P Cosgrove; Pryia Saikumar-Lakshmi; Christina E Nixon; Joslyn Foley; John Michael Ong'echa; Juliana A Otieno; Galit Alter; Christian Münz; Ann M Moormann
Journal:  Blood Adv       Date:  2018-05-22

Review 10.  Malaria - how this parasitic infection aids and abets EBV-associated Burkitt lymphomagenesis.

Authors:  Ann M Moormann; Jeffrey A Bailey
Journal:  Curr Opin Virol       Date:  2016-09-27       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.